These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32446127)

  • 1. Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET.
    Sobic Saranovic DP; Nikitovic M; Saponjski J; Grozdic Milojevic I; Paripovic L; Saranovic D; Beatovic S; Artiko VM
    Eur J Radiol; 2020 Aug; 129():109076. PubMed ID: 32446127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on
    Inagaki C; Shimoi T; Sumiyoshi Okuma H; Kawachi A; Sudo K; Shimomura A; Noguchi E; Kodaira M; Yunokawa M; Yonemori K; Shimizu C; Arakawa A; Ogawa C; Yoshida A; Fujiwara Y; Tamura K
    Med Oncol; 2019 May; 36(7):58. PubMed ID: 31104192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
    Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
    Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL
    Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.
    Sharma P; Khangembam BC; Suman KC; Singh H; Rastogi S; Khan SA; Bakhshi S; Thulkar S; Bal C; Malhotra A; Kumar R
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1036-43. PubMed ID: 23558689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma.
    Albano D; Dondi F; Schumacher RF; D'Ippolito C; Porta F; Giubbini R; Bertagna F
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e79-e86. PubMed ID: 31135716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
    Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC
    Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.
    Györke T; Zajic T; Lange A; Schäfer O; Moser E; Makó E; Brink I
    Nucl Med Commun; 2006 Jan; 27(1):17-24. PubMed ID: 16340719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.
    Hwang JP; Lim I; Kong CB; Jeon DG; Byun BH; Kim BI; Choi CW; Lim SM
    PLoS One; 2016; 11(4):e0153281. PubMed ID: 27100297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Annovazzi A; Ferraresi V; Anelli V; Covello R; Vari S; Zoccali C; Biagini R; Sciuto R
    Eur Radiol; 2021 Sep; 31(9):7012-7021. PubMed ID: 33715090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.
    Raciborska A; Bilska K; Drabko K; Michalak E; Chaber R; Pogorzała M; Połczyńska K; Sobol G; Wieczorek M; Muszyńska-Rosłan K; Rychlowska-Pruszyńska M; Rodriguez-Galindo C; Dziuk M
    Clin Transl Oncol; 2016 Feb; 18(2):189-95. PubMed ID: 26250765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.
    Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from
    Schmidkonz C; Krumbholz M; Atzinger A; Cordes M; Goetz TI; Prante O; Ritt P; Schaefer C; Agaimy A; Hartmann W; Rössig C; Fröhlich B; Bäuerle T; Dirksen U; Kuwert T; Metzler M
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1564-1575. PubMed ID: 31853559
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Seth N; Seth I; Bulloch G; Siu AHY; Guo A; Chatterjee R; MacManus M; Donnan L
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29415. PubMed ID: 34709700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different
    El-Hennawy G; Moustafa H; Omar W; Elkinaai N; Kamel A; Zaki I; Farid N; El-Kholy E
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28605. PubMed ID: 32706520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies.
    Huang T; Li F; Yan Z; Ma Y; Xiong F; Cai X; Zhang Q; Liu F; Dong J
    Medicine (Baltimore); 2018 Nov; 97(48):e13457. PubMed ID: 30508968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study.
    Johnsen B; Boye K; Rosendahl K; Biermann M; Trovik C; Aukland SM
    Clin Physiol Funct Imaging; 2016 Nov; 36(6):441-446. PubMed ID: 26039107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Metser U; Kulanthaivelu R; Salawu A; Razak A; Mak V; Li X; Langer DL; MacCrostie P; Singnurkar A
    J Nucl Med; 2023 Sep; 64(9):1371-1377. PubMed ID: 37414444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
    Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.